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SevoﬂuraneAbstract Background: Postoperative agitation is a common problem in pediatric sevoﬂurane-
based anesthesia. Dexmedetomidine has been described as a safe, long acting and effective additive
in many anesthetic and analgesic techniques. The aim of present study was to evaluate the effect of
adding dexmedetomidine to caudal lidocaine in sevoﬂurane-based anesthesia on the incidence and
severity of emergency agitation (EA) in children after surgical repair of congenital hernia.
Patients and methods: A total of 48 pediatric patients aged 18–38 months ASA I, II scheduled for
congenital hernia surgery were randomly enrolled into 2 groups: Group L patients (n= 24)
received 1% lidocaine 0.7 ml kg, while Group D patients (n= 24) received 1% lidocaine
0.7 ml kg + dexmedetomidine 2 lg/kg. Postoperatively, emergency agitation and modiﬁed
Children’s Hospital of Eastern Ontario Pain Scale (CHEOPS) scores were observed and recorded.
Results: The current study showed that the incidence and severity of agitation and modiﬁed
CHEOPS scores were signiﬁcantly lower in group D compared to group L. Also occurrence of
EA in patients in group D was signiﬁcantly lower.
Conclusion: The present study suggested that use of dexmedetomidine in addition to lidocaine was
effective to control emergency agitation after sevoﬂurane anesthesia.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Sevoﬂurane commonly used in pediatric anesthesia for inhala-
tional induction and maintenance for its several advantages:
decreased severity of airway irritation and cardiovascular
depression [1]. However, emergence agitation (EA) in children
after sevoﬂurane anesthesia is common, with a reportedincidence up to 80% [2]. The exact cause of EA in children
is unknown but several risk factors may be encountered such
as: intrinsic characteristics of an anesthetic, rapid emergence
from anesthesia, postoperative pain, preschool age, preopera-
tive anxiety, and child temperament [2]. Multiple randomized
controlled trials revealed that EA occurred more frequently
with sevoﬂurane. Rapid awakening after sevoﬂurane anesthe-
sia has been assumed to be a cause for this phenomenon [3].
Till now, there are guidelines around how to avoid emergence
agitation. Several measures have been suggested. Anxiolytic
premedications, e.g. midazolam or dexmedetomidine were
Table 1 Aono’s four point scale.
Calm 1
Not calm, but could be easily calmed 2
Moderately agitated or restless 3
Combative, exited, disorient 4
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fewer incidences of side effects, highly selective to receptors
which might permit its application in relatively high doses
for sedation and analgesia without causing vascular complica-
tions from activation of a 1-receptors [5,6]. One of the major
advantages of dexmedetomidine over other sedatives is its min-
imal respiratory effects. Indeed, respiratory rate, Carbon
Dioxide (CO2) tension, and oxygen saturation are generally
maintained during dexmedetomidine sedation in children.
Dexmedetomidine provides an interesting quality sedation that
permits arousal with gentle stimulation [7,8]. The aim of this
study was to detect the efﬁcacy of caudal dexmedetomidine –
lidocaine to control emergency agitation after sevoﬂurane
anesthesia in children after surgical repair of congenital hernia.
2. Patients and methods
After obtaining approval from the Clinical Research Ethics
Committee of South Valley University Hospital and obtaining
informed consent from the parents or guardian. A total of 48
pediatric patients with aged range between 18 and 38 months
old, The American Society of Anesthesiologists (ASA) physi-
cal status I, II of both sex scheduled for elective congenital her-
nia surgeries were included. Any patient with a history of
mental retardation or delayed development that may interfere
with pain intensity assessment, known or suspected coagulopa-
thy, congenital anomalies of the sacrum, infection at the site of
injection and known or suspected allergy to any of the studied
drugs, was excluded from this study.
This was randomized; double blind clinical study.
Randomization and enrollment to dexmedetomidine or
lidocaine was done by closed envelop. Collection of data was
performed by the physician (A.M.). Drug preparation was
done by the resident not involved in the study. Patients were
randomly assigned to one of two groups: Group L patients
(n= 24) received single dose caudal epidural analgesia using
1% lidocaine 0.7 ml/kg, while Group D patients (n= 24)
received single dose caudal epidural analgesia using 1% lido-
caine 0.7 ml/kg + dexmedetomidine 2 lg/kg.
2.1. Pre-operative evaluation
In all patients, age, body weight and baseline vital signs were
recorded. History of previous anesthesia, surgery, medical
illness, medications and allergy to used medication was
recorded; physical examination and air way assessment were
done. The following laboratory investigations were done as
hemoglobin percentage, random blood sugar, urea, creatinine
and urine analysis.
2.2. Anesthetic technique
All children were fasting for water 2 h, breast milk 4 h and
light meals for 6 h. They had 24 G intravenous access line
before arriving at operating room. All patients were pre-
medicated with 0.01 mg/kg atropine I.M. 30 min before shift-
ing to operation room.
On arrival to the operating room, the standard monitoring
was used including pulse oximetry electrocardiography non-
invasive blood pressure; and inhalational general anesthesia
was induced using 8% sevoﬂurane in 100% oxygen.Atracurium 0.5 mg/kg was given IV to facilitate endotracheal
intubation and maintain anesthesia using sevoﬂurane 1% with
controlled mechanical ventilation.
2.3. Anesthetic procedure
The patients were placed in a right lateral position and single
dose caudal epidural injection was done under strict aseptic
precautions using 25 G needle. Proper position of the needle
was conﬁrmed by the pop sensed during penetration of the
sacro-coccygeal ligament [9]. Then re-direct the needle ﬂat-
tened and advanced. Aspiration of blood or cerebrospinal ﬂuid
(C.S.F.) is performed; patients of group L were given 0.7 ml/kg
lidocaine 1%, whereas patients of group D were given
0.7 ml/kg lidocaine 1%+ dexmedetomidine parenteral prepa-
ration 2 lg/kg. By the end of surgery, reversal of remnant mus-
cle relaxant was done by atropine 0.02 mg/kg and neostigmine
0.05 mg/kg IV.
2.4. Data collection and measurements
Heart rate and arterial pressure were recorded before opera-
tion and every 5 min until the end of surgery. On return,
spontaneous ventilation extubation was established and
patient was shifted to the post-anesthesia care unit (PACU).
The time of surgery was recorded, the emergence time (deﬁned
as the time from end of surgery and closure of sevoﬂurane until
extubation). The incidence of EA was evaluated using Aono’s
four point scale [10] (Table 1). Scores of one and two were
noted as the absence of EA, and scores of three and four were
deﬁned as the presence of EA. The incidence and severity of
agitation scores (AS) were measured upon admission to the
PACU (AS 0) and in the PACU at 5 min (AS 5), at 15 min
(AS 15) and at 30 min (AS 30). Postoperative pain was mea-
sured using the modiﬁed Children’s Hospital of Eastern
Ontario Pain Scale (CHEOPS) in the PACU at (T0), (T5),
(T15) and (T30). The duration of surgery (from the time of skin
incision to the completion of the procedure), duration of
sevoﬂurane anesthesia (from mask induction to the discontinu-
ation of the inhaled anesthetic), duration of extubation (from
the discontinuation of sevoﬂurane to the removal of endotra-
cheal tube) and duration of PACU stay (from arrival to the
PACU until discharge) were recorded. We record the adverse
events such as respiratory depression, urinary retention, pruri-
tus, hypotension, bradycardia, vomiting, laryngospasm, bron-
chospasm and oxygen desaturation. Vomiting was treated with
metoclopramide 0.15 mg/kg i.e. and we record the incidence of
vomiting. It was difﬁcult to assess nausea in children.
2.5. Outcomes
The primary outcome measure was the improvement in emer-
gency agitation in dexmedetomidine group. The secondary
Table 2 Patients’ criteria and anesthetic details.
Groups
Parameters
Group L
n = 24
Group D
n = 24
P
value
Age (years) (mean±SD) 29.33±6.24 28.58±6.22 0.451
Sex (M:F) (N) 23:1 24:0
Weight (kg) (mean±SD) 15.37±2.69 14.70±3.71 0.171
Duration of anesthesia (min) (mean±SD) 51.45±3.96 50.83±4.57 0.248
Duration of surgery (min) (mean±SD) 43.20±4.13 42.79±5.09 0.301
Values were presented as mean±SD. 
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of post-anesthesia care unit stay.
2.6. Statistical analysis
Sample size estimation calculated that 24 patients were
required in each group to detect 40% incidence of EA and
about 10% reduction in EA for 0.05 levels of signiﬁcance
and power of 80%. The data were analyzed using the
Statistical Package for the Social Sciences (SPSS) version
16.0 (IBM, Chicago, IL). Data were presented as
mean ± SD. Analysis of data was performed by Chi-
square, Fisher Exact tests, T-test and ANOVA. T-test was
used to analyze parametric data between the two groups.
Chi-square and Fisher’s exact tests were used to compare
non-parametric data. To compare EA in the two groups
Chi-square or Fisher Exact tests were used. P values of
<0.05 were considered signiﬁcant.Table 3 Incidence of emergence agitation, modiﬁed children’s hos
characteristics.
Groups
Parameters
Group L
n = 24
Group D
n = 24
P
value
AONO's score
• AS 0 1.71±0.95 1.20±0.41 0.019
• AS 5 1.70±0.90 1.29±0.62 0.021
• AS 15 1.69±0.89 1.37±0.64 0.042
• AS 30 2.29±1.23 1.08±0.28 0.000
Modified CHEOPS (mean±SD)
• CHEOPS 0 4.83±1.20 4.12±0.85 0.008
• CHEOPS 5 3.62±0.76 3.00±0.78 0.000
• CHEOPS 15 3.33±1.00 2.41±0.50 0.000
• CHEOPS 30 1.54±0.65 1.16±0.38 0.009
Duration  of extubation 
(min) (mean±SD)
5.33±0.91 5.12±0.79 0.134
Duration of PACU stay (min) 
(mean±SD)
37.50±3.91 38.0±4.11 0.598
Vomiting in PACU (n) 2 3 0.132
AONO's score; CHEOPS – Children’s Hospital of
Eastern Ontario Pain Scale; PACU – Post -anesthesia care unit.3. Results
A total of 48 patients were studied, one (2.08%) of whom was
female. Their age was ranging from 18 to 38 months. There
were no signiﬁcant differences among the two studied groups
in patient characteristics, incidence of agitation before induc-
tion of anesthesia as well as the different durations of anesthe-
sia and surgery (Table 2).
3.1. Primary outcome
The incidence and severity of EA were signiﬁcantly lower in
group D compared to group L at AS0, AS5, AS15 and AS30
(Table 3). The number of patients who developed severe EA
was signiﬁcantly lower in group D and compared to group L
(Table 4). Modiﬁed CHEOPS was signiﬁcantly lower in group
D compared to group L at CHEOPS 0, CHEOPS 5, CHEOPS
15 and CHEOPS 30 (Table 3).pital of eastern Ontario pain scale characteristics and recovery
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Table 4 Show occurrence of emergency agitation in patients
of both groups.
Group L
n= 24
Group D
n= 24
P value
Time 0 14 (58.33%) 0 (0) <0.001
At 5 min 10 (41.66%) 2 (8.33%) <0.001
At 15 min 11 (45.83%) 2 (8.33%) <0.001
At 30 min 12 (50%) 0 (0) <0.001
Values were presented as number (%) of patients that developed
emergency agitation.
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Time to emergence and extubation in group L was longer com-
pared to group D. Time to discharge from the PACU was ear-
lier in group L compared to group D with no statistically
signiﬁcant differences between them as regards two times
(Table 3).
No statistically signiﬁcant difference between the two
groups as regards of vomiting.
4. Discussion
The current study aimed to evaluate the effect of caudal
dexmedetomidine combined with lidocaine to control emer-
gency agitation by sevoﬂurane in children undergoing congen-
ital hernia repair.
In our study, the incidence and severity of agitation score
were signiﬁcantly lower in group D compared to group L.
Previous studies [11–13] showed that dexmedetomidine
reduces the incidence of EA after sevoﬂurane anesthesia in
children because of their sedative and analgesic effects. In
another study, done by El-Hennawy et al. [14]; dexmedeto-
midine and clonidine were administrated in a dose of 2 lg/kg
as adjuvant with 0.25% bupivacaine caudally. They found that
the duration of analgesia was signiﬁcantly higher in the group
receiving bupivacaine–dexmedetomidine mixture or bupiva-
caine–clonidine mixture than the group receiving bupivacaine
alone [14]. Similar study was done by Neogi et al. [15] com-
pared clonidine 1 lg/kg and dexmedetomidine 1 l/kg as
adjuncts to ropivacaine 0.25% for caudal analgesia in pediatric
patients and concluded that addition of both clonidine and
dexmedetomidine with ropivacaine administered caudally sig-
niﬁcantly increases the duration of analgesia [15]. Saadawy
et al. compared caudal bupivacaine and dexmedetomidine in
mixed dose and caudal bupivacaine alone. They showed that
the incidence of agitation following sevoﬂurane anesthesia
was signiﬁcantly lower with dexmedetomidine. They found
the duration of analgesia was signiﬁcantly longer with
dexmedetomidine administration [16]. No signiﬁcant differ-
ence was found between both the groups as regards to hemo-
dynamic variables. Dexmedetomidine produced better quality
of analgesia and a prolonged duration of sedation
(P< 0.05). Using caudal dexmedetomidine 2 lg/kg with
sevoﬂurane anesthesia, we found the mean extubation time
of group L was 5.33 ± 0.91 min and in group D was
5.12 ± 0.79 min, however, the difference between the two
groups was statistically insigniﬁcant (P> 0.05) (Table 3).In our study, the emergence agitation score (Table 3) of the
group D was lower than that of group L. The difference
between the means was statistically signiﬁcant (P< 0.05).
The observations showed that group L children were agitated
and restless compared to group D children who were calm.
This improves that caudally administered dexmedetomidine
prevented the EA following sevoﬂurane administration signif-
icantly. Our results were similar to Bock et al. [17] and Boker
et al. [18] studies that compared caudal clonidine 3 lg/kg B.W.
and bupivacaine 0.25% respectively with dexmedetomidine
1 lg/kg B.W. and caudal bupivacaine 0.25% alone and
showed that the incidence of agitation following sevoﬂurane
anesthesia was signiﬁcantly lower with dexmedetomidine and
the duration of analgesia was signiﬁcantly longer with
dexmedetomidine administration [17,18]. Extubation Time
and emergence time were statistically signiﬁcantly longer in
group D in comparison with group L. in agreement to other
studies [19,20] showing that the time to awakening correlates
negatively with EA scores. The statistically signiﬁcant differ-
ence between group L and group D is of small magnitude
and is not clinically signiﬁcant. Children in both groups had
comparable durations of PACU stay. The modiﬁed
CHEOPS was signiﬁcantly lower in group D compared to
group L. Modiﬁed CHEOPS in each group decreased signiﬁ-
cantly over time. Kim et al. [21] and Ali and Abdellatif [3]
reported similar results [21,3]. We observed from our study
that there were no clinically signiﬁcant postoperative compli-
cations such as respiratory depression, urinary retention, pru-
ritus, hypotension and bradycardia. Vomiting was recorded in
two cases of group L and three cases in group D. The results of
our observations show that in addition to a good post-
operative analgesia, dexmedetomidine has a favorable safety
proﬁle and stable hemodynamics, which are in agreement with
the reports published by several other authors ([22–27]).5. Conclusion
In our study we concluded that caudal dexmedetomidine
2 lg/kg achieved less incidence of EA following sevoﬂurane
anesthesia with signiﬁcant postoperative pain relief. We ﬁnd
dexmedetomidine to be a safe and effective adjuvant for caudal
analgesia in pediatrics. It is recommended to perform more
studies to evaluate the effect of dexmedetomidine with differ-
ent doses with different concentrations of lidocaine with larger
sample size to study incidence of EA of sevoﬂurane anesthesia.
Conﬂict of interest
The authors declare no conﬂict of interest about this study.
References
[1] Gooden R, Tennantb I, Jamesa B, Augierb R, Crawford-Sykesb
A, Ehikhametalorb K, Gordon-Strachanc G, Goldson H. The
incidence of emergence delirium and risk factors following
sevoﬂurane use in pediatric patients for day case surgery,
Kingston, Jamaica. Rev Bras Anestesiol 2014;64(6):413–8.
[2] Vlajkovic GP, Sindjelic RP. Emergence delirium in children:
many questions, few answers. Anesth Analg 2007;104:84–91.
[3] Ali MA, Abdellatif AA. Prevention of sevoﬂurane related
emergence agitation in children undergoing
Prevention of sevoﬂurane agitation in children 231adenotonsillectomy: a comparison of dexmedetomidine and
propofol. Saudi J Anaesth 2013;3(7):296–300.
[4] Zhang C, Li J, Zhao D, Wang Y. Prophylactic midazolam and
clonidine for emergence from agitation in children after
emergence from sevoﬂurane anesthesia: a meta-analysis. Clin
Ther 2013;35:1622–31.
[5] Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily
M. A phase I, two-center study of the pharmacokinetics and
pharmacodynamics of dexmedetomidine in children.
Anesthesiology 2006;105:1098–110.
[6] Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M,
Miyawaki T. Dexmedetomidine enhance the local anesthetic
action of lidocaine via an alpha-2A adrenoceptor. Anesth Analg
2008;107:96–101.
[7] Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy
MO. Sedative, haemodynamic and respiratory effects of
dexmedetomidine in children undergoing magnetic resonance
imaging examination: preliminary results. Br J Anaesth
2005;94:821–4.
[8] Koroglu A, Teksan H, Sagir O, Yucel A, Toprak HI, Ersoy OM.
A comparison of the sedative, hemodynamic, and respiratory
effects of dexmedetomidine and propofol in children undergoing
magnetic resonance imaging. Anesth Analg 2006;103:63–7.
[9] Aggarwal A, Kaur H, Batra YK, Aggarwal AK, Rajeev S, Sahni
D. Anatomic consideration of caudal epidural space. Clin Anat
2009;22:730–7.
[10] Aono J, Ueda W, Mamiya K, Takimoto E, Manabe M. Greater
incidence of deliriumduring recovery from sevoﬂurane anesthesia
in preschool boys. Anesthesiology 1997;87(1298):1300.
[11] Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does
dexmedetomidine prevent emergence delirium in children after
sevoﬂurane-based general anesthesia? Paediatr Anaesth 2005;
15:1098–104.
[12] Sato M, Shirakami G, Tazuke-Nishimura M, Matsuura S,
Tanimoto K, Fukuda K. Effect of single-dose dexmedetomidine
on emergence agitation and recovery proﬁles after sevoﬂurane
anesthesia in pediatric ambulatory surgery. J Anesth
2010;24:675–82.
[13] Ibacache ME, Mun˜oz HR, Brandes V, Morales AL. Single dose
dexmedetomidine reduces agitation after sevoﬂurane anesthesia
in children. Anesth Analg 2004;98(60):63.
[14] El-Hennawy AM, Abd-Elwahab AM, Abd-Elmaksoud AM, El-
Ozairy HS, Boulis SR. Addition of clonidine or
dexmedetomidine to bupivacaine prolongs caudal analgesia in
children. Br J Anaesth 2009;103:268–74.
[15] Neogi M, Bhattacharjee DP, Dawn S, Chatterjee N. A
comparative study between clonidine and dexmedetomidineused as adjuncts to ropivacaine for caudal analgesia in
paediatric patients. J Anaesthesiol Clin Pharmacol 2010;26:
149–53.
[16] Saadawy I, Boker A, Elshahawy MA, Almazrooa A, Melibary
S, Abdellatif AA. Effect of dexmedetomidine on the
characteristics of bupivacaine in a caudal block in pediatrics.
Acta Anaesthesiol Scand 2009;53:251–6.
[17] Bock M, Kunz P, Schreckenberger R, Graf BM, Martin E,
Motsch J. Comparison of caudal and intravenous clonidine in
the prevention of agitation after sevoﬂurane in children. Br J
Anaesth 2002;88:790–6.
[18] Boker A, Saadawy I, Elshahawy MA, Almazrooa A, Melibary
S, Abdellatif AA. Effect of dexmedetomidine on the
characteristics of bupivacaine in a caudal block in pediatrics.
Acta Anaesthesiol Scand 2009;53:251–6.
[19] Aouad MT, Yazbeck-Karam VG, Nasr VG, El-Khatib MF,
Kanazi GE, Bleik JH. A single dose of propofol at the end of
surgery for the prevention of emergence agitation in children
undergoing strabismus surgery during sevoﬂurane anesthesia.
Anesthesiology 2007;107:733–8.
[20] Abu-Shahwan I. Effect of propofol on emergence behavior in
children after sevoﬂurane general anesthesia. Paediatr Anaesth
2008;18:55–9.
[21] Kim HJ, Kim HS, Kim SD, Kim CS, Kim JT, Lee KJ. Effects of
propofol and nalbuphine on emergence agitation after
sevoﬂurane anesthesia in children for strabismus surgery.
Korean J Anesthesiol 2008;55:575–8.
[22] Tobias JD, Berkenbosch JW. Initial experience with
dexmedetomidine in paediatric-aged patients. Paediatr Anaesth
2002;12:171–5.
[23] Ard J, Doyle W, Bekker A. Awake craniotomy with
dexmedetomidine in pediatric patients. J Neurosurg
Anesthesiol 2003;15:263–6.
[24] Ibacache ME, Mun˜oz HR, Brandes V, Morales AL. Single-dose
dexmedetomidine reduces agitation after sevoﬂurane anesthesia
in children. Anesth Analg 2004;98:60–3.
[25] Ramsay MA, Kuterman DL. Dexmedetomidine as a total
intravenous anesthetic agent. Anesthesiology 2004;101:787–90.
[26] Hansen TG, Henneberg SW, Walther-Larsen S, Lund J, Hansen
M. Caudal bupivacaine supplemented with caudal or
intravenous clonidine in children undergoing hypospadias
repair: a double-blind study. Br J Anaesth 2004;92:223–7.
[27] Berkenbosch JW, Wankum PC, Tobias JD. Prospective
evaluation of dexmedetomidine for noninvasive procedural
sedation in children. Pediatr Crit Care Med 2005;6:435–9.
